Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alliin (S-allyl-L-cysteine sulfoxide) is a naturally occurring organosulfur compound and a derivative of the amino acid cysteine, found most notably in fresh garlic (*Allium sativum*). It is the primary precursor to allicin, the compound responsible for the characteristic odor and many of the biological activities of crushed garlic. When garlic is physically disrupted, the enzyme alliinase (alliin lyase) converts alliin into allicin through a rapid enzymatic reaction. Alliin itself has been shown to possess antioxidant, anti-inflammatory, and potential anti-atherosclerotic properties. It is widely utilized as a dietary supplement and nutraceutical, primarily for the management of cardiovascular health, including the reduction of blood pressure and cholesterol levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alliin.